Genetic Technologies
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $4,799 | $2,399 | $3,958 | $2,436 |
Gross Profit | 2,795 | 1,397 | -1,981 | 1,558 |
EBITDA | -5,474 | -2,588 | -6,125 | -2,441 |
EBIT | -5,430 | -2,715 | -6,406 | -2,581 |
Net Income | -5,597 | -2,798 | -6,419 | -3,209 |
Net Change In Cash | 4,799 | 2,399 | 3,958 | 2,436 |
Free Cash Flow | -5,672 | -1 | -3,902 | -21 |
Cash | 1,020 | 1,020 | 3,729 | 3,729 |
Basic Shares | 149,017 | 149,017 | 4,022 | 115,417 |
Annual Financials
| Values in thousands | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|
Revenue | $7,664 | $10,347 | $6,794 | $120 |
Gross Profit | 3,904 | 6,012 | 6,473 | -240 |
EBITDA | -11,430 | -11,203 | -7,200 | -7,063 |
EBIT | -11,965 | -11,879 | -7,779 | -7,063 |
Net Income | -12,017 | -11,750 | -7,130 | -7,207 |
Net Change In Cash | 7,664 | 10,347 | 6,794 | 120 |
Free Cash Flow | -9,712 | -9,740 | -5,756 | -6,937 |
Cash | 1,020 | 7,851 | 11,731 | 20,902 |
Basic Shares | 132,217 | 3,375 | 3,070 | 2,845 |
Earnings Calls
| Quarter | EPS |
|---|---|
2023-12-31 | $0 |
2023-09-30 | $0 |
2023-06-30 | $0 |
2023-03-31 | $0 |
